Clinical Trial Update: Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating combination antithrombotic therapy to prevent recurrent ischemic stroke in intracranial atherosclerotic disease has completed enrollm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Atherosclerotic Disease
• Stroke

Snippet

Sponsor: Population Health Research Institute | Conditions: Ischemic Stroke, Intracranial Atherosclerotic Disease | Phase 3 | Status: COMPLETED